<!-- CoverPageHeader start -->
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 3.2//EN">
<HTML>
<HEAD>
<TITLE> RenaissanceRe Holdings Ltd. (Form: 8-K) </TITLE>
</HEAD>
<BODY TEXT="#000000" BGCOLOR="#FFFFFF" ALINK="#0000FF" HLINK="#FF0000" VLINK="#800080">
<A NAME="DOCUMENT_TOP">&nbsp;</A>
<P>
<!-- CoverPageHeader end --><!-- CoverPageTitle START -->
<A NAME="DOCUMENT_TOP">&nbsp;</A>
<HR NOSHADE>
<P>
<P ALIGN="CENTER">
<FONT SIZE="4">
		UNITED STATES<BR>
	SECURITIES AND EXCHANGE COMMISSION
</FONT>
<BR>
<FONT SIZE="2">
	WASHINGTON, D.C. 20549
</FONT>
<P ALIGN="CENTER">
<FONT SIZE="5">
	FORM 8-K
</FONT>
<FONT SIZE="2">

</FONT>
</P>
<P ALIGN="CENTER">
<FONT SIZE="3">
	CURRENT REPORT
</FONT>
</P>
<P ALIGN="CENTER">
<FONT SIZE="2">
	Pursuant to Section&nbsp;13 or 15(d) of the Securities Exchange Act of 1934
</FONT>
</P>
<CENTER>
<TABLE CELLSPACING="0" BORDER="0" CELLPADDING="0" WIDTH="100%">
<TR VALIGN="BOTTOM">
<TD WIDTH="51%">
	&nbsp;
</TD>
<TD WIDTH="5%">
	&nbsp;
</TD>
<TD WIDTH="44%">
	&nbsp;
</TD>
</TR>
<TR VALIGN="BOTTOM">
<TD ALIGN="CENTER" VALIGN="TOP">
<FONT SIZE="2">
	Date of Report (Date of Earliest Event Reported):
</FONT>
</TD>
<TD>
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
<TD ALIGN="CENTER" VALIGN="TOP">
<FONT SIZE="2">
	August 2, 2017
</FONT>
</TD>
</TR>
</TABLE>
<BR>
</CENTER>
<!-- CoverPageTitle END --><!-- CoverPageRegistrant START -->
<P ALIGN="CENTER"><!-- -->
<FONT SIZE="6">
	RenaissanceRe Holdings Ltd.
</FONT>
<FONT SIZE="2">
<BR>__________________________________________<BR>
	(Exact name of registrant as specified in its charter)
</FONT>
<CENTER>
<TABLE CELLSPACING="0" BORDER="0" CELLPADDING="0" WIDTH="100%">
<TR VALIGN="BOTTOM">
<TD WIDTH="33%">
	&nbsp;
</TD>
<TD WIDTH="34%">
	&nbsp;
</TD>
<TD WIDTH="33%">
	&nbsp;
</TD>
</TR>
<TR VALIGN="BOTTOM">
<TD ALIGN="CENTER" VALIGN="TOP">
<FONT SIZE="2">
	Bermuda
</FONT>
</TD>
<TD ALIGN="CENTER" VALIGN="TOP">
<FONT SIZE="2">
	001-14428
</FONT>
</TD>
<TD ALIGN="CENTER" VALIGN="TOP">
<FONT SIZE="2">
	98-0141974
</FONT>
</TD>
</TR>
<TR VALIGN="BOTTOM">
<TD ALIGN="CENTER" VALIGN="TOP">
<FONT SIZE="2">
_____________________<BR>
	(State or other jurisdiction
</FONT>
</TD>
<TD ALIGN="CENTER" VALIGN="TOP">
<FONT SIZE="2">
_____________<BR>
	(Commission
</FONT>
</TD>
<TD ALIGN="CENTER" VALIGN="TOP">
<FONT SIZE="2">
______________<BR>
	(I.R.S. Employer
</FONT>
</TD>
</TR>
<TR VALIGN="BOTTOM">
<TD ALIGN="CENTER" VALIGN="TOP">
<FONT SIZE="2">
	of incorporation)
</FONT>
</TD>
<TD ALIGN="CENTER" VALIGN="TOP">
<FONT SIZE="2">
	File Number)
</FONT>
</TD>
<TD ALIGN="CENTER" VALIGN="TOP">
<FONT SIZE="2">
	Identification No.)
</FONT>
</TD>
</TR>
<TR VALIGN="BOTTOM">
<TD ALIGN="CENTER" VALIGN="TOP">
<FONT SIZE="2">
	&nbsp;&nbsp;
</FONT>
</TD>
<TD ALIGN="CENTER" VALIGN="TOP">
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
<TD ALIGN="CENTER" VALIGN="TOP">
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
</TR>
<TR VALIGN="BOTTOM">
<TD ALIGN="CENTER" VALIGN="TOP">
<FONT SIZE="2">
	Renaissance House, 12 Crow Lane, Pembroke, Bermuda
</FONT>
</TD>
<TD ALIGN="CENTER" VALIGN="TOP">
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
<TD ALIGN="CENTER" VALIGN="TOP">
<FONT SIZE="2">
	HM 19
</FONT>
</TD>
</TR>
<TR VALIGN="BOTTOM">
<TD ALIGN="CENTER" VALIGN="TOP">
<FONT SIZE="2">
_________________________________<BR>
	(Address of principal executive offices)
</FONT>
</TD>
<TD ALIGN="CENTER" VALIGN="TOP">
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
<TD ALIGN="CENTER" VALIGN="TOP">
<FONT SIZE="2">
___________<BR>
	(Zip Code)
</FONT>
</TD>
</TR>
</TABLE>
</CENTER>
<CENTER>
<TABLE CELLSPACING="0" BORDER="0" CELLPADDING="0" WIDTH="100%">

<TR VALIGN="BOTTOM">
<TD WIDTH="51%">
	&nbsp;
</TD>
<TD WIDTH="5%">
	&nbsp;
</TD>
<TD WIDTH="44%">
	&nbsp;
</TD>
</TR>
<TR VALIGN="BOTTOM">
<TD ALIGN="CENTER" VALIGN="TOP">
<FONT SIZE="2">
	Registrant&#146;s telephone number, including area code:
</FONT>
</TD>
<TD>
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
<TD ALIGN="CENTER" VALIGN="TOP">
<FONT SIZE="2">
	(441) 295-4513
</FONT>
</TD>
</TR>
</TABLE>
</CENTER>
<P ALIGN="CENTER">
<FONT SIZE="2">
	Not Applicable
<BR>______________________________________________<BR>
	Former name or former address, if changed since last report
</FONT>
<P ALIGN="CENTER">
<FONT SIZE="2">
	&nbsp;
</FONT>
<!-- CoverPageRegistrant END --><P><FONT SIZE="2">
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any
of the following provisions:</FONT>
</P>
<P><FONT SIZE="2">
[&nbsp;&nbsp;]&nbsp;&nbsp;Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)<br>
[&nbsp;&nbsp;]&nbsp;&nbsp;Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)<br>
[&nbsp;&nbsp;]&nbsp;&nbsp;Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))<br>
[&nbsp;&nbsp;]&nbsp;&nbsp;Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))<br>
</P></FONT><tr><td colspan="3"><!-- PageBreak START -->
<P>

<DIV ALIGN="LEFT" STYLE="PAGE-BREAK-BEFORE:ALWAYS">
<A HREF="#DOCUMENT_TOP">
<U>
<B>
<FONT SIZE="2">Top of the Form</FONT>
</B>
</U>
</A>
</DIV>
<!-- PageBreak END --></td></tr><P><FONT SIZE="2">
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</FONT>
</P>
<P><FONT SIZE="2">
Emerging growth company [&nbsp;&nbsp;]<br>
</P></FONT>
<P><FONT SIZE="2">
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [&nbsp;&nbsp;]<br>
</P></FONT><!-- PageBreak START -->
<P>
<HR NOSHADE>
<DIV ALIGN="LEFT" STYLE="PAGE-BREAK-BEFORE:ALWAYS">
<A HREF="#DOCUMENT_TOP">
<U>
<B>
<FONT SIZE="2">Top of the Form</FONT>
</B>
</U>
</A>
</DIV>
<!-- PageBreak END -->



<P align="left" style="font-size: 10pt"><FONT style="font-size: 11pt"><B>Item&nbsp;5.02. Departure of Directors or Certain Officers; Election of Certain Officers; Election
of&nbsp;Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</B>
</FONT>

<P align="left" style="font-size: 11pt">(b)&nbsp;On August&nbsp;2, 2017, Ralph B. Levy, a member of the RenaissanceRe Holdings Ltd. (the &#147;Company&#148;)
Board of Directors (the &#147;Board&#148;), announced his retirement from the Board effective August&nbsp;2, 2017.
Mr.&nbsp;Levy&#146;s retirement did not involve any disagreement with the Company, the Company&#146;s management
or the Board.


<P align="left" style="font-size: 11pt">(d)&nbsp;In order to fill the vacancies on the Board created by Mr.&nbsp;Levy&#146;s retirement and the previously
announced resignation of William F. Hagerty IV on July&nbsp;20, 2017, the Board has appointed Duncan P.
Hennes as a Class&nbsp;II director and Dr.&nbsp;Valerie Rahmani as a Class&nbsp;III director, effective August&nbsp;2,
2017, each to serve until the Company&#146;s 2018 Annual General Meeting of Shareholders, or until his
or her earlier resignation or removal. The Board has determined that each of Mr.&nbsp;Hennes and Dr.
Rahmani are independent in accordance with New York Stock Exchange rules and all other applicable
laws, rules and regulations. Mr.&nbsp;Hennes has been appointed by the Board to its Compensation and
Corporate Governance Committee (the &#147;Compensation Committee&#148;) and Dr.&nbsp;Rahmani has been appointed by
the Board to its Audit Committee.


<P align="left" style="font-size: 11pt">In connection with their appointments, Mr.&nbsp;Hennes and Dr.&nbsp;Rahmani will each enter into a director
retention agreement with the Company pursuant to the Form of Director Retention Agreement, which
was previously filed as Exhibit&nbsp;10.38 to the Company&#146;s Annual Report on Form 10-K for the year
ended December&nbsp;31, 2002, filed with the SEC on March&nbsp;31, 2003, and which is incorporated herein by
reference. The director retention agreement requires the Company to indemnify directors to the
fullest extent permitted by Bermuda law, except in certain limited circumstances.


<P align="left" style="font-size: 11pt">On August&nbsp;2, 2017, the Compensation Committee determined that, in accordance with the Company&#146;s
previously disclosed compensation program for non-employee directors, Mr.&nbsp;Hennes and Dr.&nbsp;Rahmani
will receive a prorated 2017 annual cash retainer of $45,000 cash and a grant of restricted stock
with a fair market value of $140,000, vesting in three equal annual installments beginning on March
1, 2018. The restricted stock grants were made on August&nbsp;2, 2017 pursuant to the Company&#146;s 2016
Long-Term Incentive Plan, which was previously filed as Appendix&nbsp;A to the Company&#146;s Definitive
Proxy Statement on Schedule&nbsp;14A filed with the SEC on April&nbsp;1, 2016 and the Form of Director
Restricted Stock Agreement, which was previously filed as Exhibit&nbsp;10.1(a) to the Company&#146;s
Quarterly Report on Form 10-Q for the period ended June&nbsp;30, 2016, filed with the SEC on July&nbsp;27,
2016, each of which is incorporated herein by reference.


<P align="left" style="font-size: 11pt">There are no transactions with related persons involving either Mr.&nbsp;Hennes or Dr.&nbsp;Rahmani and the
Company which would require disclosure pursuant to Item 404(a) of Regulation&nbsp;S-K. There is no
arrangement or understanding between either Mr.&nbsp;Hennes or Dr.&nbsp;Rahmani and any other person pursuant
to which he or she was selected as a director.


<P align="left" style="font-size: 11pt">The Company&#146;s press release, issued August&nbsp;2, 2017, announcing the retirement of Mr.&nbsp;Levy and the
appointment of Mr.&nbsp;Hennes and Dr.&nbsp;Rahmani is being furnished as Exhibit&nbsp;99.1 to this Current Report
on Form 8-K.


<P align="left" style="font-size: 11pt"><B>Item&nbsp;9.01. Financial Statements and Exhibits.</B>


<P align="left" style="font-size: 11pt">(c)&nbsp;&nbsp;Exhibits.


<P align="left" style="font-size: 11pt">99.1 Copy of the Company&#146;s press release issued August&nbsp;2, 2017



<P align="center" style="font-size: 10pt; display: none">




<!-- v.121908 -->

<!-- PageBreak START -->
<P>
<HR NOSHADE>
<DIV ALIGN="LEFT" STYLE="PAGE-BREAK-BEFORE:ALWAYS">
<A HREF="#DOCUMENT_TOP">
<U>
<B>
<FONT SIZE="2">Top of the Form</FONT>
</B>
</U>
</A>
</DIV>
<!-- PageBreak END --><!-- SignatureHeader START -->
<P ALIGN="CENTER">
<FONT SIZE="2">
<B>
	SIGNATURES
</B>
</FONT>
</P>
<P ALIGN="LEFT">
<FONT SIZE="2">
	Pursuant to the requirements of the Securities Exchange Act of 1934, the
	registrant has duly caused this report to be signed on its behalf by the
	undersigned hereunto duly authorized.
</FONT>
</P>
<!-- SignatureHeader END --><!-- Signature START -->
<CENTER>
<TABLE CELLSPACING="0" BORDER="0" CELLPADDING="0" WIDTH="100%">
<TR VALIGN="BOTTOM">
<TD WIDTH="19%">
	&nbsp;
</TD>
<TD WIDTH="34%">
	&nbsp;
</TD>
<TD WIDTH="3%">
	&nbsp;
</TD>
<TD WIDTH="1%">
	&nbsp;
</TD>
<TD WIDTH="43%">
	&nbsp;
</TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP">
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
<TD>
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
<TD COLSPAN="3" VALIGN="TOP" ALIGN="LEFT">
<FONT SIZE="2">
	RenaissanceRe Holdings Ltd.
</FONT>
</TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP">
<FONT SIZE="2">
	&nbsp;&nbsp;
</FONT>
</TD>
<TD>
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
<TD>
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP">
<FONT SIZE="2">
<I>
	August 2, 2017
</I>
</FONT>
</TD>
<TD>
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<FONT SIZE="2">
<I>
	By:
</I>
</FONT>
</TD>
<TD>
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<FONT SIZE="2">
<I>
	/s/ Stephen H. Weinstein
</I>
<BR>
</FONT>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
<TD>
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
<TD>
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<HR SIZE="1" NOSHADE>
</TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP">
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
<TD>
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
<TD>
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<FONT SIZE="2">
<I>
	Name: Stephen H. Weinstein
</I>
</FONT>
</TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP">
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
<TD>
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
<TD>
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<FONT SIZE="2">
<I>
	Title: SVP, Group General Counsel & Corporate Secretary
</I>
</FONT>
</TD>
</TR>
</TABLE>
</CENTER>
<!-- Signature END --><!-- PageBreak START -->
<P>
<HR NOSHADE>
<DIV ALIGN="LEFT" STYLE="PAGE-BREAK-BEFORE:ALWAYS">
<A HREF="#DOCUMENT_TOP">
<U>
<B>
<FONT SIZE="2">Top of the Form</FONT>
</B>
</U>
</A>
</DIV>
<!-- PageBreak END --><P ALIGN="CENTER">
<FONT SIZE="2">
	Exhibit&nbsp;Index
</FONT>
<CENTER>
<TABLE CELLSPACING="0" BORDER="0" CELLPADDING="0" WIDTH="60%">
<TR VALIGN="BOTTOM">
<TD WIDTH="8%">
	&nbsp;
</TD>
<TD WIDTH="15%">
	&nbsp;
</TD>
<TD WIDTH="77%">
	&nbsp;
</TD>
</TR>

<BR>
<TR VALIGN="BOTTOM">
<TD NOWRAP ALIGN="LEFT">
<FONT SIZE="1">
<B>
	Exhibit No.
</B>
</FONT>
</TD>
<TD>
<FONT SIZE="1">
	&nbsp;
</FONT>
</TD>
<TD NOWRAP ALIGN="LEFT">
<FONT SIZE="1">
<B>
	Description
</B>
</FONT>
</TD>
</TR>
<TR VALIGN="BOTTOM">
<TD NOWRAP ALIGN="CENTER">
<HR SIZE="1" NOSHADE>
</TD>
<TD>
<FONT SIZE="1">
	&nbsp;
</FONT>
</TD>
<TD NOWRAP ALIGN="CENTER">
<HR ALIGN="LEFT" SIZE="1" WIDTH="88%" NOSHADE>
</TD>
</TR>





<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" WIDTH="8%" nowrap>
<FONT SIZE="2">
<DIV ALIGN="LEFT">
	99.1
</DIV>
</FONT>
</TD>
<TD WIDTH="15%">
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="77%">
<FONT SIZE="2">
<A HREF="exhibit1.htm" >
Copy of Press release dated August 2, 2017
</A>
</FONT>
</TD>
</TR></TABLE></CENTER><!-- HTMLFooter START -->
</BODY>
</HTML>
<!-- HTMLFooter END -->
[{"type": "8-K", "sequence": "1", "filename": "htm_55220.htm", "description": "LIVE FILING", "secsgml_size_bytes": 14493}]
{"company-data": {"conformed-name": "RENAISSANCERE HOLDINGS LTD", "cik": "0000913144", "assigned-sic": "6331", "irs-number": "980138020", "state-of-incorporation": "D0", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "001-14428", "film-number": "171000870"}, "business-address": {"street1": "RENAISSANCE HOUSE", "street2": "12 CROW LANE", "city": "PEMBROKE", "state": "D0", "zip": "HM19", "phone": "4412954513"}, "mail-address": {"street1": "RENAISSANCE HOUSE", "street2": "12 CROW LANE", "city": "PEMBROKE", "state": "D0", "zip": "HM19"}}
RenaissanceRe Holdings Ltd. (Form: 8-K)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported):
August 2, 2017
RenaissanceRe Holdings Ltd.
__________________________________________
(Exact name of registrant as specified in its charter)
Bermuda
001-14428
98-0141974
_____________________
(State or other jurisdiction
_____________
(Commission
______________
(I.R.S. Employer
of incorporation)
File Number)
Identification No.)
Renaissance House, 12 Crow Lane, Pembroke, Bermuda
HM 19
_________________________________
(Address of principal executive offices)
___________
(Zip Code)
Registrant's telephone number, including area code:
(441) 295-4513
Not Applicable
______________________________________________
Former name or former address, if changed since last report
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any
of the following provisions:
[  ]  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[  ]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[  ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[  ]  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Top of the Form
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company [  ]
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [  ]
Top of the Form
Item 5.02. Departure of Directors or Certain Officers; Election of Certain Officers; Election
of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
(b) On August 2, 2017, Ralph B. Levy, a member of the RenaissanceRe Holdings Ltd. (the "Company")
Board of Directors (the "Board"), announced his retirement from the Board effective August 2, 2017.
Mr. Levy's retirement did not involve any disagreement with the Company, the Company's management
or the Board.
(d) In order to fill the vacancies on the Board created by Mr. Levy's retirement and the previously
announced resignation of William F. Hagerty IV on July 20, 2017, the Board has appointed Duncan P.
Hennes as a Class II director and Dr. Valerie Rahmani as a Class III director, effective August 2,
2017, each to serve until the Company's 2018 Annual General Meeting of Shareholders, or until his
or her earlier resignation or removal. The Board has determined that each of Mr. Hennes and Dr.
Rahmani are independent in accordance with New York Stock Exchange rules and all other applicable
laws, rules and regulations. Mr. Hennes has been appointed by the Board to its Compensation and
Corporate Governance Committee (the "Compensation Committee") and Dr. Rahmani has been appointed by
the Board to its Audit Committee.
In connection with their appointments, Mr. Hennes and Dr. Rahmani will each enter into a director
retention agreement with the Company pursuant to the Form of Director Retention Agreement, which
was previously filed as Exhibit 10.38 to the Company's Annual Report on Form 10-K for the year
ended December 31, 2002, filed with the SEC on March 31, 2003, and which is incorporated herein by
reference. The director retention agreement requires the Company to indemnify directors to the
fullest extent permitted by Bermuda law, except in certain limited circumstances.
On August 2, 2017, the Compensation Committee determined that, in accordance with the Company's
previously disclosed compensation program for non-employee directors, Mr. Hennes and Dr. Rahmani
will receive a prorated 2017 annual cash retainer of $45,000 cash and a grant of restricted stock
with a fair market value of $140,000, vesting in three equal annual installments beginning on March
1, 2018. The restricted stock grants were made on August 2, 2017 pursuant to the Company's 2016
Long-Term Incentive Plan, which was previously filed as Appendix A to the Company's Definitive
Proxy Statement on Schedule 14A filed with the SEC on April 1, 2016 and the Form of Director
Restricted Stock Agreement, which was previously filed as Exhibit 10.1(a) to the Company's
Quarterly Report on Form 10-Q for the period ended June 30, 2016, filed with the SEC on July 27,
2016, each of which is incorporated herein by reference.
There are no transactions with related persons involving either Mr. Hennes or Dr. Rahmani and the
Company which would require disclosure pursuant to Item 404(a) of Regulation S-K. There is no
arrangement or understanding between either Mr. Hennes or Dr. Rahmani and any other person pursuant
to which he or she was selected as a director.
The Company's press release, issued August 2, 2017, announcing the retirement of Mr. Levy and the
appointment of Mr. Hennes and Dr. Rahmani is being furnished as Exhibit 99.1 to this Current Report
on Form 8-K.
Item 9.01. Financial Statements and Exhibits.
(c)  Exhibits.
99.1 Copy of the Company's press release issued August 2, 2017
Top of the Form
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
	registrant has duly caused this report to be signed on its behalf by the
	undersigned hereunto duly authorized.
RenaissanceRe Holdings Ltd.
August 2, 2017
By:
/s/ Stephen H. Weinstein
Name: Stephen H. Weinstein
Title: SVP, Group General Counsel & Corporate Secretary
Top of the Form
Exhibit Index
Exhibit No.
Description
99.1
Copy of Press release dated August 2, 2017